Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05757908Completed
Open-label, single-arm trial, sponsored by Koneksa. Primary endpoints: Measured FEV1 Change to Treatment Effect at Day 43 and Measured FEV1 Change and Comparison of Variability at Day 43. Started Apr 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05757908.